Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Murphy

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study InvestigatorsE L Murphy, S Glynn, K Watanabe, et al.
Transfusion|July 1, 2005
Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?Baoguang Wang, G B Schreiber, S A Glynn, et al.
Vox Sanguinis|July 24, 2014
A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countriesE M Bloch, A Shah, Z Kaidarova, et al.
International Journal of Epidemiology|October 1, 1996
A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in JamaicaE L Murphy, R Wilks, B Hanchard, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997
Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor StudyG B Schreiber, E L Murphy, J A Horton, et al.
Lancet (London, England)|November 10, 1990
Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infectionY M Chen, T H Lee, S Z Wiktor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998E L Murphy, S F Assmann, A C Collier, et al.
International Journal of Cancer|July 30, 1992
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversionA Manns, R J Wilks, E L Murphy, et al.
The New England Journal of Medicine|July 25, 1991
Lack of viral latency of human T-cell lymphotropic virus type IE J Pate, S Z Wiktor, G M Shaw, et al.
Journal of Abnormal Child Psychology|September 30, 1999
The relation of story structure properties to recall of television stories in young children with attention-deficit hyperactivity disorder and nonreferred peersE P Lorch, R P Sanchez, P van den Broek, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study InvestigatorsE L Murphy, S Glynn, K Watanabe, et al.
Transfusion|July 1, 2005
Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?Baoguang Wang, G B Schreiber, S A Glynn, et al.
Vox Sanguinis|July 24, 2014
A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countriesE M Bloch, A Shah, Z Kaidarova, et al.
International Journal of Epidemiology|October 1, 1996
A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in JamaicaE L Murphy, R Wilks, B Hanchard, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997
Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor StudyG B Schreiber, E L Murphy, J A Horton, et al.
Lancet (London, England)|November 10, 1990
Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infectionY M Chen, T H Lee, S Z Wiktor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998E L Murphy, S F Assmann, A C Collier, et al.
International Journal of Cancer|July 30, 1992
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversionA Manns, R J Wilks, E L Murphy, et al.
The New England Journal of Medicine|July 25, 1991
Lack of viral latency of human T-cell lymphotropic virus type IE J Pate, S Z Wiktor, G M Shaw, et al.
Journal of Abnormal Child Psychology|September 30, 1999
The relation of story structure properties to recall of television stories in young children with attention-deficit hyperactivity disorder and nonreferred peersE P Lorch, R P Sanchez, P van den Broek, et al.
Pageof 11